Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Miracell is a South Korean biotechnology company specializing in regenerative medicine and automated stem cell extraction technologies. The company is best known for its Smart M-Cell system, an automated platform designed to extract and concentrate high-quality autologous stem cells from bone marrow and blood at the point of care. Miracell's technology is utilized across various clinical applications, including orthopedics, cardiology, and aesthetics, to facilitate tissue repair and regeneration. By providing standardized, closed-system processing, the company aims to make regenerative cell therapies more accessible and effective for healthcare providers globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Miracell.